Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LPCN Lipocine Inc.
$1.45 0.69% +0.01
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LPCN stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Lipocine Inc. (LPCN)

Loading

Key Stats

Market cap. 12.0M
Enterprise value -11137078
Trailing PE -0.80790957488583
Forward PE -1.1612904
PEG Ratio 0.036804769522577
Enterprise to EBITDA 0.89
Enterprise to revenue -7.096
Price to book MRQ 0.54545456
Price to sales TTM 7.56421

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 1.6M
EBITDA -12509986
Diluted EPS TTM -1.85
Total Cash (MRQ) 23.3M
Current ratio (MRQ) 11.478
Operating Cash Flow (TTM) -11190794

LPCN trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LPCN News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.